We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$7.9B
AUM Growth
-$22.8B
Cap. Flow
-$20.8B
Cap. Flow %
-262.91%
Top 10 Hldgs %
15.59%
Holding
2,197
New
152
Increased
539
Reduced
888
Closed
435

Sector Composition

Rank Sector Weight
1 Healthcare 11.62%
2 Technology 9.75%
3 Industrials 9.07%
4 Financials 8.23%
5 Consumer Staples 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPS
1601
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$95K ﹤0.01%
+10,273
New +$93.6K
LNW
1602
DELISTED
Light & Wonder
LNW
$92K ﹤0.01%
10,000
-42
-0.4% -$397
ORIG
1603
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$89K ﹤0.01%
+4
New +$76.1K
IHD
1604
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$130M
$86K ﹤0.01%
11,592
+92
+0.8% +$672
ATHX
1605
DELISTED
Athersys, Inc. Common Stock
ATHX
$85K ﹤0.01%
1,564
-600
-28% -$34K
NAVB
1606
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$84K ﹤0.01%
7,973
+910
+13% +$17.9K
IO
1607
DELISTED
ION Geophysical Corporation
IO
$83K ﹤0.01%
13,333
-20
-0.1% -$150
SDT
1608
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST I
SDT
$82K ﹤0.01%
33,940
-1,600
-5% -$4.15K
CIE
1609
DELISTED
Cobalt International Energy, Inc
CIE
$82K ﹤0.01%
4,250
-186
-4% -$7.16K
IBIO icon
1610
iBio
IBIO
$71M
$81K ﹤0.01%
+23
New +$75.1K
NBSE
1611
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$80K ﹤0.01%
75
PLUR icon
1612
Pluri
PLUR
$19.2M
$79K ﹤0.01%
744
RMT
1613
Royce Micro-Cap Trust
RMT
$736M
$79K ﹤0.01%
10,783
+173
+2% +$1.26K
VTGN icon
1614
VistaGen Therapeutics
VTGN
$9.29M
$79K ﹤0.01%
+674
New +$77.2K
SCU
1615
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$79K ﹤0.01%
2,067
-18
-0.9% -$701
MBI icon
1616
MBIA
MBI
$288M
$78K ﹤0.01%
11,184
-101,337
-90% -$753K
HIO
1617
Western Asset High Income Opportunity Fund
HIO
$340M
$77K ﹤0.01%
15,706
+100
+0.6% +$478
LYG icon
1618
Lloyds Banking Group
LYG
$87.4B
$77K ﹤0.01%
25,256
-122,514
-83% -$480K
NWG icon
1619
NatWest
NWG
$71.5B
$76K ﹤0.01%
15,189
+3,160
+26% +$22.2K
SLM icon
1620
SLM Corp
SLM
$4.57B
$76K ﹤0.01%
12,153
+1,558
+15% +$10.2K
TOVX icon
1621
Theriva Biologics
TOVX
$10.2M
$76K ﹤0.01%
5
MDR
1622
DELISTED
McDermott International
MDR
$76K ﹤0.01%
5,132
-40
-0.8% -$540
RESI
1623
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$72K ﹤0.01%
7,801
+2,481
+47% +$26.2K
KGC icon
1624
Kinross Gold
KGC
$28.5B
$71K ﹤0.01%
14,654
-5,848
-29% -$27.9K
PRCP
1625
DELISTED
Perceptron Inc
PRCP
$70K ﹤0.01%
15,000

Similar funds

HighTower Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, HighTower Advisors held 2,197 positions worth $7.9B, down 74% from $30.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

HighTower Advisors withdrew a net $20.8B in Q2 2016, closing 435 positions and reducing 888 holdings. Its most notable exit was Genesis Healthcare, Inc., an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 3.2% a quarter earlier, followed by Technology and Industrials.

Against the trend, HighTower Advisors opened a new position in State Street SPDR Portfolio Short Term Treasury ETF worth $16.8M.

  • HighTower Advisors's largest Q2 2016 buy was State Street SPDR Portfolio Short Term Treasury ETF: 547,194 shares worth $16.8M.
  • HighTower Advisors added most to United Parcel Service in Q2 2016, an estimated $16.3M increase.
  • HighTower Advisors's biggest Q2 2016 reduction was iShares Russell 1000 ETF, cutting an estimated $27.6M.
  • HighTower Advisors fully exited Genesis Healthcare, Inc. in Q2 2016, selling an estimated $10.1M.
  • HighTower Advisors's ten largest holdings make up 16% of its $7.9B portfolio in Q2 2016.
  • HighTower Advisors opened 152 new positions and closed 435 in Q2 2016.
  • HighTower Advisors's portfolio value fell 74% quarter-over-quarter to $7.9B.

Based on HighTower Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.